Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine for prevention of anthracycline-associated nephrotoxicity in pediatric cancer patients
IRCT2016021915666N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of deferoxamine in nephrotoxicity (2 arms), sponsored by Shiraz University of Medical Sciences. Started Dec 2015; status: completed.
02
Drugs
deferoxamine
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on IRCT2016021915666N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016021915666N3.